The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.

Osteoporos Int · 2021 · PMC8510950 · PMID 33721032

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The narrowing treatment gap was mainly due to more patients already on anti-osteoporosis therapy at the time of fracture, increasing from 8% in 2005 to 12% in 2014, although demonstrating a decreasing trend from 2012 to 2014.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.